"Pratia to sieć profesjonalnych ośrodków badań klinicznych, zlokalizowanych w największych miastach w Polsce i Ukrainie. Naszą misją jest ułatwianie dostępu do ochrony zdrowia, aby poprawiać jakość życia i poczucie bezpieczeństwa naszych pacjentów. Badania kliniczne realizowane przez Centrum Medyczne Pratia oznaczają: - kompleksowe i bezpłatne badania diagnostyczne – zarówno podczas kwalifikacji do badań klinicznych, jak i w trakcie ich trwania, - dostęp do profesjonalnej opieki medycznej – lekarzy specjalistów z wielu dziedzin medycyny, - przyjazną atmosferę oraz pełen komfort podczas leczenia – elastycznie dopasowujemy się do Twoich potrzeb oraz oczekiwań jako pacjenta."

During the past decade, Pratia Onkologia Katowice conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pratia Onkologia Katowice" #1 sponsor was "Janssen Research & Development, LLC" with 6 trials, followed by "Loxo Oncology, Inc." with 4 trials sponsored, "Pfizer" with 4 trials sponsored, "ADC Therapeutics S.A." with 2 trials sponsored and "Genmab" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pratia Onkologia Katowice" #1 collaborator was "Eli Lilly and Company" with 4 trials as a collaborator, "AbbVie" with 1 trials as a collaborator and "Telios Pharma, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Pratia Onkologia Katowice" are "Chronic Lymphocytic Leukemia" (5 trials), "Multiple Myeloma" (5 trials), "Myelofibrosis" (4 trials), "Small Lymphocytic Lymphoma" (4 trials) and "Follicular Lymphoma" (2 trials). Many other conditions were trialed in "Pratia Onkologia Katowice" in a lesser frequency.

Most popular intervention types in "Pratia Onkologia Katowice" are "Drug" (25 trials), "Biological" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Daratumumab" (5 trials), "Dexamethasone" (5 trials), "Rituximab" (5 trials), "Pomalidomide" (4 trials) and "Elranatamab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Pratia Onkologia Katowice" are 26 trials for "All" genders.

Currently, there are NaN active trials in "Pratia Onkologia Katowice". undefined are not yet recruiting, 21 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Pratia Onkologia Katowice, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Pratia Onkologia Katowice, 6 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".